|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/343 | |
| A61P 25/14 | |||
| A61P 25/16 | |||
| A61P 25/28 |
| (11) | Number of the document | 3270913 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16715099.4 |
| Date of filing the European patent application | 2016-03-17 | |
| (97) | Date of publication of the European application | 2018-01-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2016/051511 |
| Date | 2016-03-17 |
| (87) | Number | WO 2016/147146 |
| Date | 2016-09-22 |
| (30) | Number | Date | Country code |
| 15108294 | 2015-03-17 | PT | |
| 15173723 | 2015-06-24 | EP |
| (72) |
ESPINHEIRA DE S MACIEL, Patr cia, PT
TEIXEIRA DE CASTRO, Andreia Cristiana, PT
DE JALES MONTEIRO DE SOUSA, Ana Lu sa, PT
TEIXEIRA ESTEVES, Ana Sofia, PT
CARVALHO SOUSA, Nuno Jorge, PT
|
| (73) |
Universidade do Minho,
Largo do Paēo, 4704-553 Braga,
PT
|
| (54) | CITALOPRAM OR ESCITALOPRAM FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| CITALOPRAM OR ESCITALOPRAM FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES |